The numbers ABT said it expected, in its earnings releases of the last 3 years, next to what it then reported for the same period. Each target links to the sentence in the release; each result to the 10-Q or 10-K it was first reported in.
Of 2 range targets with a reported result: 2 came in above the last range given, 0 within it, 0 below it.
| Target | What the company said | Reported | Result |
|---|---|---|---|
| Diluted EPS (company-defined) Fiscal 2026 |
Given $5.55 to $5.80 release 2026-01-22
Lowered $5.38 to $5.58 release 2026-04-16
Raised $5.45 to $5.60 release 2026-07-16
Narrowed $5.50 to $5.55 release 2026-10-21
|
– | No standard number |
The company's wordsAbbott projects full-year 2026 adjusted diluted EPS of $5.55 to $5.80, which reflects 10 percent growth at the midpoint ABBOTT PARK, Ill., Jan. 22, 2026 — Abbott today announced financial results for the fourth quarter ended Dec. 31, 2025. release 2026-01-22 – Abbott projects full-year 2026 adjusted diluted EPS of $5.38 to $5.58, which includes $0.20 of dilution related to the acquisition of Exact Sciences ABBOTT PARK, Ill., April 16, 2026 — Abbott today announced financial results for the first quarter ended March 31, 2026. release 2026-04-16 – Abbott raises full-year 2026 adjusted diluted EPS guidance range to $5.45 to $5.60, compared to previous range of $5.38 to $5.58 release 2026-07-16 Abbott reaffirms the midpoint of previously provided full-year 2026 adjusted diluted EPS guidance range and tightens the range to $5.50 to $5.55. release 2026-10-21 | |||
| Diluted EPS (company-defined) Q4 of fiscal 2026 |
Given $1.62 to $1.67 release 2026-10-21
|
– | No standard number |
The company's wordsAbbott projects fourth-quarter 2026 adjusted diluted earnings per share of $1.62 to $1.67. release 2026-10-21 | |||
| Diluted EPS (company-defined) Q3 of fiscal 2026 |
Given $1.38 to $1.46 release 2026-07-16
|
– | No standard number |
The company's wordsAbbott projects third-quarter 2026 adjusted diluted earnings per share of $1.38 to $1.46 . release 2026-07-16 | |||
| Diluted EPS (company-defined) Q2 of fiscal 2026 |
Given $1.25 to $1.31 release 2026-04-16
|
– | No standard number |
The company's wordsAbbott projects second-quarter 2026 adjusted diluted earnings per share of $1.25 to $1.31. release 2026-04-16 | |||
| Diluted EPS (company-defined) Fiscal 2025 (ended 2025-12-31) |
Given $5.05 to $5.25 release 2025-01-22
Kept $5.05 to $5.25 release 2025-04-16
Narrowed $5.10 to $5.20 release 2025-07-17
Narrowed $5.12 to $5.18 release 2025-10-15
|
– | No standard number |
The company's wordsAbbott projects full-year 2025 adjusted diluted EPS of $5.05 to $5.25, which reflects double-digit growth at the midpoint. release 2025-01-22 Abbott projects full-year 2025 adjusted diluted earnings per share of $5.05 to $5.25 and second-quarter 2025 adjusted diluted earnings per share of $1.23 to $1.27. release 2025-04-16 Abbott projects full-year 2025 adjusted diluted EPS of $5.10 to $5.20, which reflects double-digit growth at the midpoint. release 2025-07-17 Abbott reaffirms the midpoint of previously provided full-year 2025 adjusted diluted EPS guidance range and narrows the range to $5.12 to $5.18, reflecting double-digit growth at the midpoint. release 2025-10-15 | |||
| Diluted EPS (company-defined) Fiscal 2024 (ended 2024-12-31) |
Given $4.50 to $4.70 release 2024-01-24
Raised $4.55 to $4.70 release 2024-04-17
Raised $4.61 to $4.71 release 2024-07-18
Raised $4.64 to $4.70 release 2024-10-16
|
– | No standard number |
The company's wordsIssues 2024 Financial Outlook … Abbott issues full-year 2024 guidance for diluted EPS on a GAAP basis of $3.20 to $3.40 and full-year adjusted diluted EPS of $4.50 to $4.70. release 2024-01-24 Excluding specified items, projected adjusted diluted earnings per share would be $4.55 to $4.70 for the full-year 2024. release 2024-04-17 Excluding specified items, projected adjusted diluted earnings per share would be $4.61 to $4.71 for the full-year 2024. release 2024-07-18 Excluding specified items, projected adjusted diluted earnings per share would be $4.64 to $4.70 for the full-year 2024. release 2024-10-16 | |||
| Diluted EPS Q4 of fiscal 2024 |
Given $0.96 to $1.02 release 2024-10-16
|
– | Not found in XBRL |
The company's wordsAbbott projects fourth-quarter 2024 diluted earnings per share under GAAP of $0.96 to $1.02. release 2024-10-16 | |||
| Diluted EPS (company-defined) Q4 of fiscal 2024 |
Given $1.31 to $1.37 release 2024-10-16
|
– | No standard number |
The company's wordsExcluding specified items, projected adjusted diluted earnings per share would be $1.31 to $1.37 for the fourth quarter 2024. release 2024-10-16 | |||
| Diluted EPS Q3 of fiscal 2024 |
Given $0.85 to $0.89 release 2024-07-18
|
$0.94 10-Q filed 2024-10-31 |
Above the range |
The company's wordsAbbott projects third-quarter 2024 diluted earnings per share under GAAP of $0.85 to $0.89. release 2024-07-18 | |||
| Diluted EPS (company-defined) Q3 of fiscal 2024 |
Given $1.18 to $1.22 release 2024-07-18
|
– | No standard number |
The company's wordsExcluding specified items, projected adjusted diluted earnings per share would be $1.18 to $1.22 for the third quarter 2024. release 2024-07-18 | |||
| Diluted EPS Q2 of fiscal 2024 |
Given $0.69 to $0.73 release 2024-04-17
|
$0.74 10-Q filed 2024-07-31 |
Above the range |
The company's wordsAbbott projects second-quarter 2024 diluted earnings per share under GAAP of $0.69 to $0.73. release 2024-04-17 | |||
| Diluted EPS (company-defined) Q2 of fiscal 2024 |
Given $1.08 to $1.12 release 2024-04-17
|
– | No standard number |
The company's wordsExcluding specified items, projected adjusted diluted earnings per share would be $1.08 to $1.12 for the second quarter 2024. release 2024-04-17 | |||
1 target far from the company's reported total, so not compared (usually a target for one product, segment or definition)
- Diluted EPS, Fiscal 2024 (ended 2024-12-31): said $3.34 to $3.40, reported $7.64. The company's words
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (12 releases since 2024-01-24), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.
Work on ABT in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/ABT/export.csv") into a cell.